PR Log - LevelStock.com Momentum Trade Alert on BioTechnology Power3
Document Sample


PR Log - Global Press Release Distribution
LevelStock.com Momentum Trade Alert on BioTechnology: Power3 Medical Products, Inc.
OTCBB: PWRM
By LevelStock.com
Dated: Jan 02, 2010
LevelStock.com issues technical and fundamental stock alerts. Investors that are looking to receive stock
alerts on penny stocks can subscribe to our FREE Newsletter today.
LevelStock.com Issues Momentum Alert on Bio Technology: Power3 Medical Products, Inc. OTCBB:
PWRM
Power3 Medical Products, Inc. OTCBB: PWRM. The stock broke resistance at .14 on Friday and closed up
13% on 4 million volume.
About Power3 Medical Products, Inc.:
Power3 Medical Products (OTCBB:PWRM) (www.Power3Medical.com) is a leading bio-medical
company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways,
and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3's
patent-pending technologies are being used to develop screening and diagnostic tests for the early detection
and prognosis of disease, identify protein biomarkers, and drug targets. Diagnostic tests are targeted toward
markets with critical unmet needs in areas including neurodegenerative disease (NuroPro(R)) and breast
cancer (BC-SeraPro(TM)). Power3 expects to complete phase II clinical validation trials of its blood serum
diagnostics for Alzheimer's disease (NuroPro-AD), Parkinson's disease (NuroPro-PD) and breast cancer in
2010, followed by filings with the FDA. Power3 operates a state-of-the-art CLIA certified laboratory in The
Woodlands (Houston), Texas. Power3 continues to evolve and enhance its IP portfolio, employing sensitive
and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of
highly selective blood-based tests for ALS, Alzheimer's, and Parkinson's diseases, and breast cancer.
To Receive Our Newsletters Visit http://www.levelstock.com/
FORWARD LOOKING STATEMENTS
Information in LevelStock.com emails, press releases, news distributions and content on LevelStock.com
website may contain “forward looking statements” in this action may be identified through the use of words
such as “expects,” “will,” “anticipates,”estimates,” “believes,” “may,” or by statements indicating certain
actions “may,” “could,” or “might” occur. Forward looking statements as defined under Section 27A of the
Securities Act of 1933 and Section 21B,21E of the Securities Exchange Act of 1934. An example of
forward-looking information are statements relating to the future anticipated direction of the industry, plans
for future expansion, various business development activities, planned capital expenditures, future funding
sources, anticipated sales growth and potential contracts. These and similar forward statements are subject
to a number of known and unknown risks and uncertainties outside our control that could cause actual
operations or results to differ materially from those anticipated.
###
Page 1/2
PR Log - Global Press Release Distribution
About LevelStock.com
We are an investor community and investors relations website specializing in emerging growth stocks in
today’s Hot Sectors and providing a platform of services for SmallCap, MicroCap, NanoCap Companies.
LevelStock.com is not a registered or licensed investment advisor. Our Full Disclaimer can be read at
http://levelstock.bondwaresite.com/news.php?viewStory=19
Category Advertising, Business
Tags pennystocks, stock alerts, biotechnology, investors
Email Click to email author
Address 288 Grove Street Suite 181
City/Town Braintree
State/Province Massachusetts
Zip 01284
Country United States
Page 2/2
Related docs
Get documents about "